{
    "xml": "<topic id=\"PHP1756\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/salbutamol\" basename=\"salbutamol\" title=\"SALBUTAMOL\">\n<title>SALBUTAMOL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_726\" namespace=\"/interactions/list-of-drug-interactions/sympathomimetics-beta2/salbutamol\">Salbutamol</xref>\n</p>\n<data name=\"vtmid\">91143003</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_265796086\" title=\"Beta2 agonists (short-acting)\">Beta2 agonists (short-acting)</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34629\" title=\"SELECTIVE BETA2 AGONISTS\" namespace=\"/drug-classes/selective-beta2-agonists\">SELECTIVE BETA2 AGONISTS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n<p outputclass=\"synonyms\">Albuterol</p>\r\n</body>\n<topic id=\"PHP56256\" outputclass=\"indicationsAndDose\" rev=\"1.84\" parent=\"/drugs/salbutamol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Asthma</p>\n<p outputclass=\"therapeuticIndication\">Other conditions associated with reversible airways obstruction</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>4&#8239;mg 3&#8211;4 times a day, maximum single dose 8&#8239;mg (but unlikely to provide much extra benefit or to be tolerated), inhalation route preferred over oral route, use elderly dose for sensitive patients.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 2&#8239;mg 3&#8211;4 times a day, maximum single dose 8&#8239;mg (but unlikely to provide much extra benefit or to be tolerated), inhalation route preferred over oral route.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By subcutaneous injection or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;micrograms every 4&#8239;hours if required.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By slow intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>250&#8239;micrograms, repeated if necessary, injection to be diluted to a concentration of 50&#8239;micrograms/mL, reserve intravenous beta<sub>2</sub> agonists for those in whom inhaled therapy cannot be used reliably.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 5&#8239;micrograms/minute, adjusted according to response and heart rate, usual dose 3&#8211;20&#8239;micrograms/minute, higher doses may be required, reserve intravenous beta<sub>2</sub> agonists for those in whom inhaled therapy cannot be used reliably.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By inhalation of aerosol</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>100&#8211;200&#8239;micrograms, up to 4 times a day for persistent symptoms.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By inhalation of nebulised solution</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;5&#8239;mg, repeated up to 4 times daily or more frequently in severe cases.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of allergen- or exercise-induced bronchospasm</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of aerosol</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;micrograms.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Moderate, severe, or life-threatening acute asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of nebulised solution</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;4 years</p>\n<p>2.5&#8239;mg, then 2.5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 5&#8211;11 years</p>\n<p>2.5&#8211;5&#8239;mg, then 2.5&#8211;5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>5&#8239;mg, then 5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8239;mg, then 5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Moderate and severe acute asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of aerosol</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>2&#8211;10&#8239;puffs, each puff is to be inhaled separately, then 2&#8211;10&#8239;puffs every 10&#8211;20&#8239;minutes or when required, give via large volume spacer, give via close-fitting face mask in children under 3 years.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8211;10&#8239;puffs, each puff is to be inhaled separately, then 2&#8211;10&#8239;puffs every 10&#8211;20&#8239;minutes or when required, give via large volume spacer, give via close-fitting face mask in children under 3 years.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Exacerbation of reversible airways obstruction (including nocturnal asthma)</p>\n<p outputclass=\"therapeuticIndication\">Prophylaxis of allergen- or exercise-induced bronchospasm</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By inhalation of aerosol</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child</p>\n<p>100&#8211;200&#8239;micrograms, up to 4 times a day for persistent symptoms.</p>\n</li>\n</ul>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;1 year</p>\n<p>100&#8239;micrograms/kg 3&#8211;4 times a day (max. per dose 2&#8239;mg), inhalation route preferred over oral route.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;5 years</p>\n<p>1&#8211;2&#8239;mg 3&#8211;4 times a day, inhalation route preferred over oral route.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 6&#8211;11 years</p>\n<p>2&#8239;mg 3&#8211;4 times a day, inhalation route preferred over oral route.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>2&#8211;4&#8239;mg 3&#8211;4 times a day, inhalation route preferred over oral route.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Chronic asthma</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth using modified-release medicines</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 3&#8211;11 years</p>\n<p>4&#8239;mg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>8&#8239;mg twice daily.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>8&#8239;mg twice daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Uncomplicated premature labour (between 22 and 37 weeks of gestation) (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 10&#8239;micrograms/minute, rate increased gradually according to response at 10-minute intervals until contractions diminish then increase rate slowly until contractions cease (maximum rate 45&#8239;micrograms/minute), maintain rate for 1 hour after contractions have stopped, then gradually reduce by 50% every 6 hours, maximum duration 48 hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"pharmacokinetics\">\n<title>Pharmacokinetics</title>\n<p>At recommended inhaled doses, the duration of action of salbutamol is about 3 to 5 hours.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56212\" outputclass=\"unlicensedUse\" rev=\"1.12\" parent=\"/drugs/salbutamol\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Not licensed for use in hyperkalaemia.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in children</p>\n<p>Syrup and tablets not licensed for use in children under 2 years.</p>\n<p>Modified-release tablets not licensed for use in children under 3 years.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use in children</p>\n<p>Injection and solution for intravenous infusion not licensed for use in children under 12 years.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>Administration of undiluted salbutamol injection through a central venous catheter is not licensed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56342\" outputclass=\"contraindications\" rev=\"1.8\" parent=\"/drugs/salbutamol\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<sectiondiv outputclass=\"additionalContraindications\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithIndications\">\n<p outputclass=\"title\">When used for uncomplicated premature labour under specialist supervision</p>\n<p>\n<ph outputclass=\"routesAndIndications\">with <ph outputclass=\"route\">intravenous</ph> use for uncomplicated premature labour under specialist supervision</ph>\n<ph outputclass=\"contraindication\">abruptio placenta</ph> (in adults); <ph outputclass=\"contraindication\">antepartum haemorrhage</ph> (in adults); <ph outputclass=\"contraindication\">cord compression</ph> (in adults); <ph outputclass=\"contraindication\">eclampsia</ph> (in adults); <ph outputclass=\"contraindication\">history of cardiac disease</ph> (in adults); <ph outputclass=\"contraindication\">intra-uterine fetal death</ph> (in adults); <ph outputclass=\"contraindication\">intra-uterine infection</ph> (in adults); <ph outputclass=\"contraindication\">placenta praevia</ph> (in adults); <ph outputclass=\"contraindication\">pulmonary hypertension</ph> (in adults); <ph outputclass=\"contraindication\">severe pre-eclampsia</ph> (in adults); <ph outputclass=\"contraindication\">significant risk factors for myocardial ischaemia</ph> (in adults); <ph outputclass=\"contraindication\">threatened miscarriage</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56354\" outputclass=\"cautions\" rev=\"1.18\" parent=\"/drugs/salbutamol\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With intravenous use</p>\n<p>\n<ph outputclass=\"caution\">mild to moderate pre-eclampsia (when used for uncomplicated premature labour)</ph> (in adults); <ph outputclass=\"caution\">suspected cardiovascular disease (should be assessed by a cardiologist before initiating therapy for uncomplicated premature labour)</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56226\" outputclass=\"sideEffects\" rev=\"1.29\" parent=\"/drugs/salbutamol\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Lactic acidosis (with high doses)</ph>; <ph outputclass=\"sideEffect\">nausea</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithIndications\">\n<p outputclass=\"title\">When used for uncomplicated premature labour</p>\n<p>\n<ph outputclass=\"routesAndIndications\">with <ph outputclass=\"route\">intravenous</ph> use for uncomplicated premature labour</ph>\n<ph outputclass=\"sideEffect\">bronchospasm</ph> (in adults); <ph outputclass=\"sideEffect\">muscle tension</ph> (in adults); <ph outputclass=\"sideEffect\">pulmonary oedema</ph> (in adults); <ph outputclass=\"sideEffect\">vomiting</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56359\" outputclass=\"breastFeeding\" parent=\"/drugs/salbutamol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Inhaled drugs for asthma can be taken as normal during breast-feeding.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56207\" outputclass=\"monitoringRequirements\" parent=\"/drugs/salbutamol\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>In uncomplicated premature labour it is important to monitor blood pressure, pulse rate (should not exceed 120 beats per minute), ECG (discontinue treatment if signs of myocardial ischaemia develop), blood glucose and lactate concentrations, and the patient&#8217;s fluid and electrolyte status (avoid over-hydration&#8212;discontinue drug immediately and initiate diuretic therapy if pulmonary oedema occurs).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56367\" outputclass=\"directionsForAdministration\" rev=\"1.32\" parent=\"/drugs/salbutamol\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>continuous intravenous infusion</i>, dilute to a concentration of 200&#8239;micrograms/mL with Glucose 5% <i>or</i> Sodium Chloride 0.9%. If fluid-restricted, can be given undiluted through central venous catheter [unlicensed].</p>\n<p>For <i>intravenous injection</i>, dilute to a concentration of 50&#8239;micrograms/mL with Glucose 5%, Sodium Chloride 0.9%, <i>or</i> Water for injections.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\n</p>\n<p>For <i>nebulisation</i>, dilute nebuliser solution with a suitable volume of sterile Sodium Chloride 0.9% solution according to nebuliser type and duration of administration; salbutamol and ipratropium bromide solutions are compatible and can be mixed for nebulisation.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>bronchodilation</i> by <i>continuous intravenous infusion</i>, dilute to a concentration of 200&#8239;micrograms/mL with glucose 5% or sodium chloride 0.9%.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>premature labour</i> by <i>continuous intravenous infusion</i>, dilute with glucose 5% to a concentration of 200&#8239;micrograms/mL for use in a syringe pump <i>or</i> for other infusion methods (preferably <i>via</i> controlled infusion device), dilute to a concentration of 20&#8239;micrograms/mL; close attention to patient's fluid and electrolyte status essential.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP56244\" outputclass=\"patientAndCarerAdvice\" rev=\"1.27\" parent=\"/drugs/salbutamol\">\n<title>Patient and carer advice</title>\n<body>\r\n\r\n\r\n<section outputclass=\"patientResources\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">In children</p>\r\n<p outputclass=\"title\">Medicines for Children leaflet: Salbutamol inhaler for asthma and wheeze</p>\r\n<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/salbutamol-inhaler-for-asthma-and-wheeze\">www.medicinesforchildren.org.uk/salbutamol-inhaler-for-asthma-and-wheeze</xref>\n</p>\n</sectiondiv>\n</section>\r\n<section outputclass=\"generalPatientAdvice\">\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\r\n</p>\r\n<p>\r\n<i>For inhalation by aerosol or dry powder</i>, advise patients and carers not to exceed prescribed dose and to follow manufacturer&#8217;s directions; if a previously effective dose of inhaled salbutamol fails to provide at least 3 hours relief, a doctor&#8217;s advice should be obtained as soon as possible.</p>\n</sectiondiv>\r\n<sectiondiv>\r\n<p outputclass=\"specificity\">When used by <ph outputclass=\"route\">inhalation</ph>\r\n</p>\r\n<p>\r\n<i>For inhalation by nebuliser</i>, the dose given by nebuliser is substantially higher than that given by inhaler. Patients should therefore be warned that it is dangerous to exceed the prescribed dose and they should seek medical advice if they fail to respond to the usual dose of the respirator solution.</p>\n</sectiondiv>\n</section>\r\n\r\n\r\n\r\n\r\n\r\n</body>\n</topic>\n<topic id=\"PHP1756-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/salbutamol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76433\" title=\"Tablet\" namespace=\"/drugs/salbutamol/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76439\" title=\"Oral solution\" namespace=\"/drugs/salbutamol/oral-solution\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76464\" title=\"Solution for injection\" namespace=\"/drugs/salbutamol/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76478\" title=\"Solution for infusion\" namespace=\"/drugs/salbutamol/solution-for-infusion\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76445\" title=\"Pressurised inhalation\" namespace=\"/drugs/salbutamol/pressurised-inhalation\">Pressurised inhalation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76485\" title=\"Inhalation powder\" namespace=\"/drugs/salbutamol/inhalation-powder\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76471\" title=\"Nebuliser liquid\" namespace=\"/drugs/salbutamol/nebuliser-liquid\">Nebuliser liquid</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP85620\" namespace=\"/drugs/ipratropium-with-salbutamol\" title=\"IPRATROPIUM WITH SALBUTAMOL\" count=\"1\" rel=\"backlink\">IPRATROPIUM WITH SALBUTAMOL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP98619\" namespace=\"/guidance/prescribing-in-dental-practice\" title=\"Prescribing in dental practice\" count=\"5\" rel=\"backlink\">Prescribing in dental practice</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78111\" namespace=\"/treatment-summaries/antihistamines-allergen-immunotherapy-and-allergic-emergencies\" title=\"Antihistamines, allergen immunotherapy and allergic emergencies\" count=\"1\" rel=\"backlink\">Antihistamines, allergen immunotherapy and allergic emergencies</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78123\" namespace=\"/treatment-summaries/-acute-medical-emergency\" title=\" acute, medical emergency\" count=\"2\" rel=\"backlink\"> acute, medical emergency</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78360\" namespace=\"/treatment-summaries/asthma\" title=\"Asthma\" count=\"4\" rel=\"backlink\">Asthma</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78465\" namespace=\"/treatment-summaries/bronchodilators\" title=\"Bronchodilators\" count=\"5\" rel=\"backlink\">Bronchodilators</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78566\" namespace=\"/treatment-summaries/fluids-and-electrolytes\" title=\"Fluids and electrolytes\" count=\"1\" rel=\"backlink\">Fluids and electrolytes</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78629\" namespace=\"/treatment-summaries/obstetrics\" title=\"Obstetrics\" count=\"1\" rel=\"backlink\">Obstetrics</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_726\" namespace=\"/interactions/list-of-drug-interactions/sympathomimetics-beta2/salbutamol\" title=\"Salbutamol\" count=\"1\" rel=\"link\">Salbutamol</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34629\" namespace=\"/drug-classes/selective-beta2-agonists\" title=\"SELECTIVE BETA2 AGONISTS\" count=\"1\" rel=\"link\">SELECTIVE BETA2 AGONISTS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76433\" namespace=\"/drugs/salbutamol/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76439\" namespace=\"/drugs/salbutamol/oral-solution\" title=\"Oral solution\" count=\"1\" rel=\"link\">Oral solution</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76464\" namespace=\"/drugs/salbutamol/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76478\" namespace=\"/drugs/salbutamol/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76445\" namespace=\"/drugs/salbutamol/pressurised-inhalation\" title=\"Pressurised inhalation\" count=\"1\" rel=\"link\">Pressurised inhalation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76485\" namespace=\"/drugs/salbutamol/inhalation-powder\" title=\"Inhalation powder\" count=\"1\" rel=\"link\">Inhalation powder</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76471\" namespace=\"/drugs/salbutamol/nebuliser-liquid\" title=\"Nebuliser liquid\" count=\"1\" rel=\"link\">Nebuliser liquid</xref>\n</links>\n</topic>",
    "id": "PHP1756",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/salbutamol",
    "basename": "salbutamol",
    "title": "SALBUTAMOL",
    "interactants": [
        {
            "id": "bnf_int_726",
            "label": "Salbutamol"
        }
    ],
    "vtmid": "91143003",
    "drugClassification": [
        "Beta2 agonists (short-acting)"
    ],
    "inheritsFromClass": [
        "SELECTIVE BETA2 AGONISTS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Albuterol"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Asthma",
                        "html": "Asthma"
                    },
                    {
                        "textContent": "Other conditions associated with reversible airways obstruction",
                        "html": "Other conditions associated with reversible airways obstruction"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of nebulised solution"
                    ],
                    "textContent": "By inhalation of nebulised solution",
                    "html": "By inhalation of nebulised solution"
                },
                "adult": [
                    {
                        "textContent": "4 mg 3&#8211;4 times a day, maximum single dose 8 mg (but unlikely to provide much extra benefit or to be tolerated), inhalation route preferred over oral route, use elderly dose for sensitive patients.",
                        "html": "<p>4&#8239;mg 3&#8211;4 times a day, maximum single dose 8&#8239;mg (but unlikely to provide much extra benefit or to be tolerated), inhalation route preferred over oral route, use elderly dose for sensitive patients.</p>"
                    },
                    {
                        "textContent": "Initially 2 mg 3&#8211;4 times a day, maximum single dose 8 mg (but unlikely to provide much extra benefit or to be tolerated), inhalation route preferred over oral route.",
                        "html": "<p>Initially 2&#8239;mg 3&#8211;4 times a day, maximum single dose 8&#8239;mg (but unlikely to provide much extra benefit or to be tolerated), inhalation route preferred over oral route.</p>",
                        "ageGroup": "elderly"
                    },
                    {
                        "textContent": "500 micrograms every 4 hours if required.",
                        "html": "<p>500&#8239;micrograms every 4&#8239;hours if required.</p>"
                    },
                    {
                        "textContent": "250 micrograms, repeated if necessary, injection to be diluted to a concentration of 50 micrograms/mL, reserve intravenous beta2 agonists for those in whom inhaled therapy cannot be used reliably.",
                        "html": "<p>250&#8239;micrograms, repeated if necessary, injection to be diluted to a concentration of 50&#8239;micrograms/mL, reserve intravenous beta<sub>2</sub> agonists for those in whom inhaled therapy cannot be used reliably.</p>"
                    },
                    {
                        "textContent": "Initially 5 micrograms/minute, adjusted according to response and heart rate, usual dose 3&#8211;20 micrograms/minute, higher doses may be required, reserve intravenous beta2 agonists for those in whom inhaled therapy cannot be used reliably.",
                        "html": "<p>Initially 5&#8239;micrograms/minute, adjusted according to response and heart rate, usual dose 3&#8211;20&#8239;micrograms/minute, higher doses may be required, reserve intravenous beta<sub>2</sub> agonists for those in whom inhaled therapy cannot be used reliably.</p>"
                    },
                    {
                        "textContent": "100&#8211;200 micrograms, up to 4 times a day for persistent symptoms.",
                        "html": "<p>100&#8211;200&#8239;micrograms, up to 4 times a day for persistent symptoms.</p>"
                    },
                    {
                        "textContent": "2.5&#8211;5 mg, repeated up to 4 times daily or more frequently in severe cases.",
                        "html": "<p>2.5&#8211;5&#8239;mg, repeated up to 4 times daily or more frequently in severe cases.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of allergen- or exercise-induced bronchospasm",
                        "html": "Prophylaxis of allergen- or exercise-induced bronchospasm"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of aerosol"
                    ],
                    "textContent": "By inhalation of aerosol",
                    "html": "By inhalation of aerosol"
                },
                "adult": [
                    {
                        "textContent": "200 micrograms.",
                        "html": "<p>200&#8239;micrograms.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Moderate, severe, or life-threatening acute asthma",
                        "html": "Moderate, severe, or life-threatening acute asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of nebulised solution"
                    ],
                    "textContent": "By inhalation of nebulised solution",
                    "html": "By inhalation of nebulised solution"
                },
                "child": [
                    {
                        "textContent": "2.5 mg, then 2.5 mg every 20&#8211;30 minutes or when required, give via oxygen-driven nebuliser if available.",
                        "html": "<p>2.5&#8239;mg, then 2.5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>",
                        "ageGroup": "1 month&#8211;4 years"
                    },
                    {
                        "textContent": "2.5&#8211;5 mg, then 2.5&#8211;5 mg every 20&#8211;30 minutes or when required, give via oxygen-driven nebuliser if available.",
                        "html": "<p>2.5&#8211;5&#8239;mg, then 2.5&#8211;5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>",
                        "ageGroup": "5&#8211;11 years"
                    },
                    {
                        "textContent": "5 mg, then 5 mg every 20&#8211;30 minutes or when required, give via oxygen-driven nebuliser if available.",
                        "html": "<p>5&#8239;mg, then 5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "5 mg, then 5 mg every 20&#8211;30 minutes or when required, give via oxygen-driven nebuliser if available.",
                        "html": "<p>5&#8239;mg, then 5&#8239;mg every 20&#8211;30&#8239;minutes or when required, give via oxygen-driven nebuliser if available.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Moderate and severe acute asthma",
                        "html": "Moderate and severe acute asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "inhalation of aerosol"
                    ],
                    "textContent": "By inhalation of aerosol",
                    "html": "By inhalation of aerosol"
                },
                "child": [
                    {
                        "textContent": "2&#8211;10 puffs, each puff is to be inhaled separately, then 2&#8211;10 puffs every 10&#8211;20 minutes or when required, give via large volume spacer, give via close-fitting face mask in children under 3 years.",
                        "html": "<p>2&#8211;10&#8239;puffs, each puff is to be inhaled separately, then 2&#8211;10&#8239;puffs every 10&#8211;20&#8239;minutes or when required, give via large volume spacer, give via close-fitting face mask in children under 3 years.</p>"
                    }
                ],
                "adult": [
                    {
                        "textContent": "2&#8211;10 puffs, each puff is to be inhaled separately, then 2&#8211;10 puffs every 10&#8211;20 minutes or when required, give via large volume spacer, give via close-fitting face mask in children under 3 years.",
                        "html": "<p>2&#8211;10&#8239;puffs, each puff is to be inhaled separately, then 2&#8211;10&#8239;puffs every 10&#8211;20&#8239;minutes or when required, give via large volume spacer, give via close-fitting face mask in children under 3 years.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Exacerbation of reversible airways obstruction (including nocturnal asthma)",
                        "html": "Exacerbation of reversible airways obstruction (including nocturnal asthma)"
                    },
                    {
                        "textContent": "Prophylaxis of allergen- or exercise-induced bronchospasm",
                        "html": "Prophylaxis of allergen- or exercise-induced bronchospasm"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "child": [
                    {
                        "textContent": "100&#8211;200 micrograms, up to 4 times a day for persistent symptoms.",
                        "html": "<p>100&#8211;200&#8239;micrograms, up to 4 times a day for persistent symptoms.</p>"
                    },
                    {
                        "textContent": "100 micrograms/kg 3&#8211;4 times a day (max. per dose 2 mg), inhalation route preferred over oral route.",
                        "html": "<p>100&#8239;micrograms/kg 3&#8211;4 times a day (max. per dose 2&#8239;mg), inhalation route preferred over oral route.</p>",
                        "ageGroup": "1 month&#8211;1 year"
                    },
                    {
                        "textContent": "1&#8211;2 mg 3&#8211;4 times a day, inhalation route preferred over oral route.",
                        "html": "<p>1&#8211;2&#8239;mg 3&#8211;4 times a day, inhalation route preferred over oral route.</p>",
                        "ageGroup": "2&#8211;5 years"
                    },
                    {
                        "textContent": "2 mg 3&#8211;4 times a day, inhalation route preferred over oral route.",
                        "html": "<p>2&#8239;mg 3&#8211;4 times a day, inhalation route preferred over oral route.</p>",
                        "ageGroup": "6&#8211;11 years"
                    },
                    {
                        "textContent": "2&#8211;4 mg 3&#8211;4 times a day, inhalation route preferred over oral route.",
                        "html": "<p>2&#8211;4&#8239;mg 3&#8211;4 times a day, inhalation route preferred over oral route.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Chronic asthma",
                        "html": "Chronic asthma"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth using modified-release medicines"
                    ],
                    "textContent": "By mouth using modified-release medicines",
                    "html": "By mouth using modified-release medicines"
                },
                "child": [
                    {
                        "textContent": "4 mg twice daily.",
                        "html": "<p>4&#8239;mg twice daily.</p>",
                        "ageGroup": "3&#8211;11 years"
                    },
                    {
                        "textContent": "8 mg twice daily.",
                        "html": "<p>8&#8239;mg twice daily.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "8 mg twice daily.",
                        "html": "<p>8&#8239;mg twice daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Uncomplicated premature labour (between 22 and 37 weeks of gestation) (specialist use only)",
                        "html": "Uncomplicated premature labour (between 22 and 37 weeks of gestation) (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "Initially 10 micrograms/minute, rate increased gradually according to response at 10-minute intervals until contractions diminish then increase rate slowly until contractions cease (maximum rate 45 micrograms/minute), maintain rate for 1 hour after contractions have stopped, then gradually reduce by 50% every 6 hours, maximum duration 48 hours.",
                        "html": "<p>Initially 10&#8239;micrograms/minute, rate increased gradually according to response at 10-minute intervals until contractions diminish then increase rate slowly until contractions cease (maximum rate 45&#8239;micrograms/minute), maintain rate for 1 hour after contractions have stopped, then gradually reduce by 50% every 6 hours, maximum duration 48 hours.</p>"
                    }
                ]
            }
        ],
        "pharmacokinetics": [
            {
                "type": "pharmacokinetics",
                "title": "Pharmacokinetics",
                "textContent": "At recommended inhaled doses, the duration of action of salbutamol is about 3 to 5 hours.",
                "html": "<p>At recommended inhaled doses, the duration of action of salbutamol is about 3 to 5 hours.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Not licensed for use in hyperkalaemia.",
                "html": "<p>Not licensed for use in hyperkalaemia.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With oral use in children",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Syrup and tablets not licensed for use in children under 2 years.\n\nModified-release tablets not licensed for use in children under 3 years.",
                "html": "<p>Syrup and tablets not licensed for use in children under 2 years.</p><p>Modified-release tablets not licensed for use in children under 3 years.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With intravenous use or subcutaneous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use or <ph outputclass=\"route\">subcutaneous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous",
                        "subcutaneous"
                    ]
                },
                "textContent": "Injection and solution for intravenous infusion not licensed for use in children under 12 years.",
                "html": "<p>Injection and solution for intravenous infusion not licensed for use in children under 12 years.</p>"
            },
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Administration of undiluted salbutamol injection through a central venous catheter is not licensed.",
                "html": "<p>Administration of undiluted salbutamol injection through a central venous catheter is not licensed.</p>"
            }
        ]
    },
    "contraindications": {
        "cautionsOrContraindicationsWithIndications": [
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "abruptio placenta in adults",
                "html": "abruptio placenta in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "antepartum haemorrhage in adults",
                "html": "antepartum haemorrhage in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "cord compression in adults",
                "html": "cord compression in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "eclampsia in adults",
                "html": "eclampsia in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "history of cardiac disease in adults",
                "html": "history of cardiac disease in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "intra-uterine fetal death in adults",
                "html": "intra-uterine fetal death in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "intra-uterine infection in adults",
                "html": "intra-uterine infection in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "placenta praevia in adults",
                "html": "placenta praevia in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "pulmonary hypertension in adults",
                "html": "pulmonary hypertension in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "severe pre-eclampsia in adults",
                "html": "severe pre-eclampsia in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "significant risk factors for myocardial ischaemia in adults",
                "html": "significant risk factors for myocardial ischaemia in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithIndications",
                "textContent": "threatened miscarriage in adults",
                "html": "threatened miscarriage in adults",
                "specificity": {
                    "routes": [
                        "intravenous"
                    ],
                    "textContent": "When used for uncomplicated premature labour under specialist supervision",
                    "html": "When used for uncomplicated premature labour under specialist supervision",
                    "indications": [
                        "uncomplicated premature labour under specialist supervision"
                    ],
                    "patientType": "adults"
                }
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "mild to moderate pre-eclampsia (when used for uncomplicated premature labour) in adults",
                "html": "mild to moderate pre-eclampsia (when used for uncomplicated premature labour) in adults",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ],
                    "patientType": "adults"
                }
            },
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "suspected cardiovascular disease (should be assessed by a cardiologist before initiating therapy for uncomplicated premature labour) in adults",
                "html": "suspected cardiovascular disease (should be assessed by a cardiologist before initiating therapy for uncomplicated premature labour) in adults",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With intravenous use",
                    "routes": [
                        "intravenous"
                    ],
                    "patientType": "adults"
                }
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Lactic acidosis (with high doses)",
                        "html": "Lactic acidosis (with high doses)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithIndications",
                        "textContent": "bronchospasm in adults",
                        "html": "bronchospasm in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "routes": [
                                "intravenous"
                            ],
                            "textContent": "When used for uncomplicated premature labour",
                            "html": "When used for uncomplicated premature labour",
                            "indications": [
                                "uncomplicated premature labour"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithIndications",
                        "textContent": "muscle tension in adults",
                        "html": "muscle tension in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "routes": [
                                "intravenous"
                            ],
                            "textContent": "When used for uncomplicated premature labour",
                            "html": "When used for uncomplicated premature labour",
                            "indications": [
                                "uncomplicated premature labour"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithIndications",
                        "textContent": "pulmonary oedema in adults",
                        "html": "pulmonary oedema in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "routes": [
                                "intravenous"
                            ],
                            "textContent": "When used for uncomplicated premature labour",
                            "html": "When used for uncomplicated premature labour",
                            "indications": [
                                "uncomplicated premature labour"
                            ],
                            "patientType": "adults"
                        }
                    },
                    {
                        "type": "sideEffectsWithIndications",
                        "textContent": "vomiting in adults",
                        "html": "vomiting in adults",
                        "frequency": "notKnown",
                        "specificity": {
                            "routes": [
                                "intravenous"
                            ],
                            "textContent": "When used for uncomplicated premature labour",
                            "html": "When used for uncomplicated premature labour",
                            "indications": [
                                "uncomplicated premature labour"
                            ],
                            "patientType": "adults"
                        }
                    }
                ]
            }
        }
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Inhaled drugs for asthma can be taken as normal during breast-feeding.",
                "html": "<p>Inhaled drugs for asthma can be taken as normal during breast-feeding.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "In uncomplicated premature labour it is important to monitor blood pressure, pulse rate (should not exceed 120 beats per minute), ECG (discontinue treatment if signs of myocardial ischaemia develop), blood glucose and lactate concentrations, and the patient&#8217;s fluid and electrolyte status (avoid over-hydration&#8212;discontinue drug immediately and initiate diuretic therapy if pulmonary oedema occurs).",
                "html": "<p>In uncomplicated premature labour it is important to monitor blood pressure, pulse rate (should not exceed 120 beats per minute), ECG (discontinue treatment if signs of myocardial ischaemia develop), blood glucose and lactate concentrations, and the patient&#8217;s fluid and electrolyte status (avoid over-hydration&#8212;discontinue drug immediately and initiate diuretic therapy if pulmonary oedema occurs).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For continuous intravenous infusion, dilute to a concentration of 200 micrograms/mL with Glucose 5% or Sodium Chloride 0.9%. If fluid-restricted, can be given undiluted through central venous catheter [unlicensed].\n\nFor intravenous injection, dilute to a concentration of 50 micrograms/mL with Glucose 5%, Sodium Chloride 0.9%, or Water for injections.",
                "html": "<p>For <i>continuous intravenous infusion</i>, dilute to a concentration of 200&#8239;micrograms/mL with Glucose 5% <i>or</i> Sodium Chloride 0.9%. If fluid-restricted, can be given undiluted through central venous catheter [unlicensed].</p><p>For <i>intravenous injection</i>, dilute to a concentration of 50&#8239;micrograms/mL with Glucose 5%, Sodium Chloride 0.9%, <i>or</i> Water for injections.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "For nebulisation, dilute nebuliser solution with a suitable volume of sterile Sodium Chloride 0.9% solution according to nebuliser type and duration of administration; salbutamol and ipratropium bromide solutions are compatible and can be mixed for nebulisation.",
                "html": "<p>For <i>nebulisation</i>, dilute nebuliser solution with a suitable volume of sterile Sodium Chloride 0.9% solution according to nebuliser type and duration of administration; salbutamol and ipratropium bromide solutions are compatible and can be mixed for nebulisation.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For bronchodilation by continuous intravenous infusion, dilute to a concentration of 200 micrograms/mL with glucose 5% or sodium chloride 0.9%.",
                "html": "<p>For <i>bronchodilation</i> by <i>continuous intravenous infusion</i>, dilute to a concentration of 200&#8239;micrograms/mL with glucose 5% or sodium chloride 0.9%.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For premature labour by continuous intravenous infusion, dilute with glucose 5% to a concentration of 200 micrograms/mL for use in a syringe pump or for other infusion methods (preferably via controlled infusion device), dilute to a concentration of 20 micrograms/mL; close attention to patient's fluid and electrolyte status essential.",
                "html": "<p>For <i>premature labour</i> by <i>continuous intravenous infusion</i>, dilute with glucose 5% to a concentration of 200&#8239;micrograms/mL for use in a syringe pump <i>or</i> for other infusion methods (preferably <i>via</i> controlled infusion device), dilute to a concentration of 20&#8239;micrograms/mL; close attention to patient's fluid and electrolyte status essential.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "patientResources": [
            {
                "type": "patientResources",
                "references": [
                    {
                        "id": "http://www.medicinesforchildren.org.uk/salbutamol-inhaler-for-asthma-and-wheeze",
                        "label": "www.medicinesforchildren.org.uk/salbutamol-inhaler-for-asthma-and-wheeze"
                    }
                ],
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "title": "Medicines for Children leaflet: Salbutamol inhaler for asthma and wheeze",
                "textContent": "www.medicinesforchildren.org.uk/salbutamol-inhaler-for-asthma-and-wheeze",
                "html": "<p>\n<xref format=\"html\" href=\"http://www.medicinesforchildren.org.uk/salbutamol-inhaler-for-asthma-and-wheeze\">www.medicinesforchildren.org.uk/salbutamol-inhaler-for-asthma-and-wheeze</xref>\n</p>"
            }
        ],
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "For inhalation by aerosol or dry powder, advise patients and carers not to exceed prescribed dose and to follow manufacturer&#8217;s directions; if a previously effective dose of inhaled salbutamol fails to provide at least 3 hours relief, a doctor&#8217;s advice should be obtained as soon as possible.",
                "html": "<p>\r\n<i>For inhalation by aerosol or dry powder</i>, advise patients and carers not to exceed prescribed dose and to follow manufacturer&#8217;s directions; if a previously effective dose of inhaled salbutamol fails to provide at least 3 hours relief, a doctor&#8217;s advice should be obtained as soon as possible.</p>"
            },
            {
                "type": "generalPatientAdvice",
                "specificity": {
                    "textContent": "When used by inhalation",
                    "html": "When used by <ph outputclass=\"route\">inhalation</ph>",
                    "routes": [
                        "inhalation"
                    ]
                },
                "textContent": "For inhalation by nebuliser, the dose given by nebuliser is substantially higher than that given by inhaler. Patients should therefore be warned that it is dangerous to exceed the prescribed dose and they should seek medical advice if they fail to respond to the usual dose of the respirator solution.",
                "html": "<p>\r\n<i>For inhalation by nebuliser</i>, the dose given by nebuliser is substantially higher than that given by inhaler. Patients should therefore be warned that it is dangerous to exceed the prescribed dose and they should seek medical advice if they fail to respond to the usual dose of the respirator solution.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76433",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76439",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76464",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76478",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76445",
                "label": "Pressurised inhalation",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76485",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76471",
                "label": "Nebuliser liquid",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP85620",
                "label": "IPRATROPIUM WITH SALBUTAMOL",
                "type": "drug"
            }
        ],
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP98619",
                "label": "Prescribing in dental practice",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78111",
                "label": "Antihistamines, allergen immunotherapy and allergic emergencies",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78123",
                "label": "acute, medical emergency",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78360",
                "label": "Asthma",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78465",
                "label": "Bronchodilators",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78566",
                "label": "Fluids and electrolytes",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78629",
                "label": "Obstetrics",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_726",
                "label": "Salbutamol",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34629",
                "label": "SELECTIVE BETA2 AGONISTS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76433",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76439",
                "label": "Oral solution",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76464",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76478",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76445",
                "label": "Pressurised inhalation",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76485",
                "label": "Inhalation powder",
                "type": "medicinalForm"
            },
            {
                "id": "PHP76471",
                "label": "Nebuliser liquid",
                "type": "medicinalForm"
            }
        ]
    }
}